Intriguingly, a recent large genome-wide association study (GWAS) has identified EGFR as one of the most significant novel risk genes for late onset Alzheimer’s disease (LOAD) [13] raising the question of the possible participation of SHIP2 in EGFR function/turnover in AD. This evidence concerns the gene EGFR and Alzheimer disease.